產品詳情
簡單介紹：
Anti-FEZ1抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-FEZ1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-FEZ1
Cat. Number:
Anti-FEZ1抗體KL-9721R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Frequent loss of heterozygosity (LOH) at human chromosome 8p22-p21 is associated with various tumors including prostate and breast cancer. The 8p22-p21 region contains the FEZ1 gene, which is altered in tumors of the esophagus, prostate and breast. The FEZ1 protein (also known as leucine zipper putative tumor suppressor orAnti-FEZ1抗體 LZTS1) contains a DNA-binding leucine zipper motif. FEZ1 is expressed in normal breast and prostate, but alterations in FEZ1 expression result in abnormal cell growth. The absence of FEZ1 expression is characteristic of breast and prostate cancer cell lines as well as primary breast and pro-state tumors. This absence of FEZ1 may be due to several factors, including mutations in the FEZ1 gene or hypermethylation of the CpG island flanking the FEZ1 promoter region. FEZ1 acts as a negative regulator of cell growth. During cell-cycle progression, FEZ1 localizes to microtubule components and is hyperphosphorylated by cAMP-dependent kinase.
Also known as:
Fasciculation and elongation protein zeta 1;Anti-FEZ1抗體 Fasciculation and elongation protein zeta-1; Fez 1; Fez; Fez-like zinc finger protein; FEZ1; FEZ1_HUMAN; Fezl; Forebrain embryonic zinc-finger like protein; Zpf312; Zygin 1; Zygin I; Zygin-1; Zygin1; ZyginI.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human FEZ1.
●
Predicted Molecular Weight: 45kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-FEZ1抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working dilutions must beAnti-FEZ1抗體 determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must beAnti-FEZ1抗體 determined by the end user.
kl246Mu01 DNA甲基轉移酶3B(DNMT3B)多克隆抗體 Polyclonal Antibody to DNA Methyltransferase 3B (DNMT3B)
kl251Hu01 惡性腦腫瘤缺失蛋白1(DMBT1)多克隆抗體 Polyclonal Antibody to Deleted In Malignant Brain Tumors 1 (DMBT1)
kl256Hu01 δ樣蛋白4(δLL4)多克隆抗體 Polyclonal Antibody to Delta Like Protein 4 (dLL4)
kl256Ra01 δ樣蛋白4(δLL4)多克隆抗體 Polyclonal Antibody to Delta Like Protein 4 (dLL4)
kl265Hu01 Diaphanous同源物1(DIAPH1)多克隆抗體 Polyclonal Antibody to Diaphanous Homolog 1 (DIAPH1)
kl271Hu01 二氫乳清酸脫氫酶(DHODH)多克隆抗體 Polyclonal Antibody to Dihydroorotate Dehydrogenase (DHODH)
kl272Hu01 二酰甘油-O-酰基轉移酶同源物2(DGAT2)多克隆抗體 Polyclonal Antibody to Diacylglycerol-O-Acyltransferase Homolog 2 (DGAT2)
kl273Hu01 二酰甘油-O-酰基轉移酶同源物1(DGAT1)多克隆抗體 Polyclonal Antibody to Diacylglycerol-O-Acyltransferase Homolog 1 (DGAT1)
kl273Mu01 二酰甘油-O-酰基轉移酶同源物1(DGAT1)多克隆抗體 Polyclonal Antibody to Diacylglycerol-O-Acyltransferase Homolog 1 (DGAT1)
kl273Ra01 二酰甘油-O-酰基轉移酶同源物1(DGAT1)多克隆抗體 Polyclonal Antibody to Diacylglycerol-O-Acyltransferase Homolog 1 (DGAT1)
kl280Hu01 D-天冬氨酸氧化酶(DDO)多克隆抗體 Polyclonal Antibody to D-Askltate Oxidase (DDO)
kl292Ra01 白蛋白啟動子D位點結合蛋白(DBP)多克隆抗體 Polyclonal Antibody to D Site Of Albumin Promoter Binding Protein (DBP)
kl297Hu01 D-氨基酸氧化酶激活因子(DAOA)多克隆抗體 Polyclonal Antibody to D-amino Acid Oxidase Activator (DAOA)
kl314Hu01 二-N-乙酰殼二糖酶(CTBS)多克隆抗體 Polyclonal Antibody to Di-N-Acetyl Chitobiase (CTBS)
kl322Hu01 半胱氨酸蛋白酶抑制劑B(CSTB)多克隆抗體 Polyclonal Antibody to Cystatin B (CSTB)
kl323Hu01 半胱氨酸蛋白酶抑制劑2(CST2)多克隆抗體 Polyclonal Antibody to Cystatin 2 (CST2)
kl324Hu01 半胱氨酸蛋白酶抑制劑4(CST4)多克隆抗體 Polyclonal Antibody to Cystatin 4 (CST4)
kl326Hu01 半胱氨酸蛋白酶抑制劑6(CST6)多克隆抗體 Polyclonal Antibody to Cystatin 6 (CST6)
kl330Hu01 半胱氨酸蛋白酶抑制劑1(CST1)多克隆抗體 Polyclonal Antibody to Cystatin 1 (CST1)
kl332Bo01 酪蛋白β(CSN2)多克隆抗體 Polyclonal Antibody to Casein Beta (CSN2)
